Dr. William CHO
Queen Elizabeth Hospital
FHKIMLS, FHKSMDS, Chartered Scientist (UK), FIBMS (UK)

Dr William Cho primarily focused on cancer studies with the aim of identifying biomarkers for cancer diagnosis, treatment prediction, and prognosis. As a seasoned researcher, Dr Cho has contributed over 700 SCI papers, including Lancet, Lancet Oncology, Annals of Oncology, Molecular Cancer, Advanced Science, Nature Communications, PNAS, Science Advances, Journal of Thoracic Oncology, Military Medical Research, Journal of Extracellular Vesicles, Clinical Cancer Research, Theranostics and Seminars in Cancer Biology, among others. These publications cover a wide range of topics including cancer biomarkers, non-coding RNAs, extracellular vesicles, drug repurposing and Chinese medicine. Additionally, Dr Cho has crafted over three dozen books, including "MicroRNAs in Cancer Translational Research", "An Omics Perspective on Cancer Research", "Supportive Cancer Care with Chinese Medicine", "Drug Repurposing in Cancer Therapy: Approaches and Applications", “Resistance to Anti-CD20 Antibodies and Approaches for Their Reversal”, and “Biochemical and Molecular Pharmacology in Drug Discovery” to name a few. Dr. Cho's publications have garnered over 38,000 citations, reflecting his significant global influence. He has been ranked among the world's top 2% most influential scientists annually since 2017. His consistent impact is evidenced by his recognition as a Highly Cited Researcher in 2023 and 2024 by Clarivate.